Wellcome awards Novartis institute €5.15 million for vaccine project

The Wellcome Trust has awarded €5.15 million to a vaccine institute run by Novartis AG to investigate a new bivalent vaccine for Typhoid fever.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom